A study was conducted to see if it were possible to attain the ability to lucid dream through a drug. In 2018, galantamine was given to 121 patients in a double-blind, placebo-controlled trial, the only one of its kind. Some participants found as much as a 42 percent increase in their ability to lucid dream, compared to self-reports from the past six months, and ten people experienced a lucid dream for the first time. It is theorized that galantamine allows acetylcholine to build up, leading to greater recollection and awareness during dreaming.